Bastien Joubert

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Complications neurologiques des immunothérapies anti-cancéreuses
  Bulletin de l'Académie Nationale de Médecine 2026 DOI: 10.1016/j.banm.2025.12.009
  +Save
• Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders
  Neurology Neuroimmunology & Neuroinflammation 2026 DOI: 10.1212/NXI.0000000000200538
  +Save
• Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease
  Neurology Neuroimmunology & Neuroinflammation 2025 DOI: 10.1212/NXI.0000000000200498
  +Save
• Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
  Neurology Neuroimmunology & Neuroinflammation 2024 DOI: 10.1212/NXI.0000000000200287
  +Save
• Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis
  Neurology 2024 DOI: 10.1212/WNL.0000000000209284
  +Save
• Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents
  Revue Neurologique 2023 DOI: 10.1016/j.neurol.2023.03.015
  +Save
• Glial Fibrillary Acidic Protein Autoimmunity
  Neurology 2022 DOI: 10.1212/WNL.0000000000013087
  +Save
• How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update
  Journal of Neurology 2022 DOI: 10.1007/s00415-021-10870-6
  +Save
• Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis
  Neurology 2022 DOI: 10.1212/WNL.0000000000200020
  +Save
• Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex
  Annals of Neurology 2022 DOI: 10.1002/ana.26345
  +Save